Archer Investment Corporation’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300 Hold
50
﹤0.01% 1166
2025
Q4
$359 Hold
50
﹤0.01% 1099
2025
Q3
$534 Hold
50
﹤0.01% 1105
2025
Q2
$484 Hold
50
﹤0.01% 1081
2025
Q1
$745 Hold
50
﹤0.01% 1023
2024
Q4
$746 Hold
50
﹤0.01% 1020
2024
Q3
$957 Hold
50
﹤0.01% 983
2024
Q2
$1.03K Sell
50
-1,032
-95% -$20.5K ﹤0.01% 959
2024
Q1
$20.3K Hold
1,082
0.01% 538
2023
Q4
$15.6K Sell
1,082
-5
-0.5% -$68 0.01% 574
2023
Q3
$18.9K Buy
1,087
+476
+78% +$9.93K 0.01% 518
2023
Q2
$12.7K Sell
611
-10,809
-95% -$235K ﹤0.01% 576
2023
Q1
$266K Hold
11,420
0.1% 194
2022
Q4
$319K Sell
11,420
-30
-0.3% -$767 0.12% 175
2022
Q3
$268K Buy
11,450
+2,030
+22% +$61.3K 0.11% 179
2022
Q2
$318K Hold
9,420
0.13% 169
2022
Q1
$329K Sell
9,420
-36
-0.4% -$1.23K 0.12% 176
2021
Q4
$288K Buy
9,456
+1,395
+17% +$45.4K 0.1% 187
2021
Q3
$264K Buy
8,061
+1,210
+18% +$38.7K 0.1% 193
2021
Q2
$207K Buy
+6,851
New +$226K 0.08% 191

Other funds holding OGN

Archer Investment Corporation's OGN Position: Q1 2026 in Review

Archer Investment Corporation held its Organon & Co (OGN) position steady in Q1 2026 at 50 shares worth $300. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Archer Investment Corporation first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $329K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Archer Investment Corporation held 50 shares of Organon & Co worth $300 as of Q1 2026.
  • Archer Investment Corporation left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #1166 holding.
  • Archer Investment Corporation first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Archer Investment Corporation's Organon & Co position peaked at $329K in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.